Study wrapper · #1050
Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Wei Y, Gong Y, Gong J, et al. Journal of obstetrics and gynaecology. 2026.
DOI: 10.1080/01443615.2026.2701996PubMed: 42495930
Editor's note
A small (n=53) non-randomized observational comparison, so the findings are hypothesis-generating rather than definitive. Semaglutide was associated with one-year weight loss but higher two-year weight regain (55.6%) than the structured lifestyle arm. Group sizes were uneven and outcomes were not adjusted for confounders, so read the comparative results with caution.
Plain-language abstract
This small prospective observational study compared semaglutide, sleeve gastrectomy, and a structured lifestyle programme for weight control in 53 endometrial cancer patients pursuing fertility-sparing care. Semaglutide produced weight loss at one year but was associated with more weight regain by two years than the lifestyle programme.
Related coverage
Mixed
Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide.
International journal of qualitative studies on health and well-beingn=——2026
Weak / none
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.
Journal of enzyme inhibition and medicinal chemistryn=——2026
Weak / none
A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'.
Scandinavian journal of primary health caren=——2026